The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 29, 2020

Filed:

Jun. 20, 2019
Applicant:

Orum Therapeutics Inc., Daejeon, KR;

Inventors:

Yong Sung Kim, Suwon, KR;

Ji Sun Kim, Go-yang, KR;

Jae Yeong Park, Suwon, KR;

Seong Wook Park, Suwon, KR;

Sei Yong Jun, Paju, KR;

Dong-Ki Choi, Daejeon, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/64 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07K 7/64 (2013.01); C07K 16/28 (2013.01); C07K 2317/92 (2013.01); C07K 2319/035 (2013.01); C07K 2319/30 (2013.01);
Abstract

Presented herein are cyclic peptides that specifically bind to a cell surface molecule, thereby allowing cell/tissue-specific targeting. The cyclic peptides can be attached to an agent, for example, a polypeptide such as an antibody, e.g., a cell-penetrating antibody. Cyclic peptide-containing cell/tissue-specific cell-penetrating antibodies described herein are capable of targeted delivery in a cell type-specific or tissue-specific (i.e., cell/tissue-specific) manner. The cell/tissue-specific cell-penetrating antibodies described herein can be used as an effective anticancer agent for cancer that overexpresses a cell membrane protein that specifically binds to the fused cyclic peptides.


Find Patent Forward Citations

Loading…